See below for all PrecisionLife Disease Studies which provide detailed background and analysis of our research, objectives and findings.
See below for all PrecisionLife Disease Studies which provide detailed background and analysis of our research, objectives and findings.
We built combinatorial risk scores that predict which type of complications a type-II diabetes patient is likely to experience.
We stratified a schizophrenia patient population to identify disease sub-groups and new targets for treatment responsive and resistant groups.
We revealed clear genetic differences between T2 / non-T2 asthma patients, leading to stratification biomarkers and novel, validated targets for non-T2 asthma.
We found 33 novel genes that were strongly associated with ALS and have selected 10 targets of significant interest for drug discovery screening.
Please enter your email address if you would like to be kept informed of our work here at PrecisionLife. Note that our Privacy Policy and Terms & Conditions apply.
If you have any questions or would like to speak to us in terms of potential collaborations or partnership opportunities, please get in touch using the form below or email info@precisionlife.com and we will get back to you as soon as we can. Note that our Privacy Policy and Terms & Conditions apply.
Unit 8b Bankside
Hanborough Business Park
Long Hanborough, OX29 8LJ
1 Broadway Fl 14
Cambridge
MA 02142-1187
Agern Allé 3
DK-2970
Hørsholm
CIC Ul
Chmielna 73m
00-801 Warszawa
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.